[Biotherapies for the treatment of asthma: are they the treatment of the future?].
Tonnel
A-B
AB
Service de Pneumologie et Immunoallergologie, CHRU de Lille - 59037 Lille Cedex. ab-tonnel@chru-lille.fr
Denis
G
G
Lelong
J
J
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001507:Beclomethasone / Q000008:administration & dosage / Q000627:therapeutic use; D001691:Biological Therapy; D002648:Child; D018849:Controlled Clinical Trials as Topic; D004195:Disease Models, Animal; D004802:Eosinophilia / Q000188:drug therapy; D000068800:Etanercept; D005544:Forecasting; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015848:Interleukin-5 / Q000276:immunology; D000069444:Omalizumab; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015848:Interleukin-5; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069444:Omalizumab; D007073:Immunoglobulin E; D001507:Beclomethasone; D000068800:Etanercept